Frequency of gross hematuria shortly after percutaneous coronary intervention

American Journal of Cardiology

Volumn 88, Issue 1, 2001, Pages 71-73

  Sanchez, Pedro L ^a   Rubenstein, Mark H ^a   Harrell, Lari C ^a   Colon Hernandez, Pedro J ^a   Choo, Joseph K ^a   Palacios, Igor F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; HEPARIN; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; BALLOON CATHETER; BLADDER CANCER; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DISEASE ACTIVITY; DISEASE COURSE; ENDOMETRIUM CARCINOMA; FEMALE; FIBRINOLYTIC THERAPY; HEMATURIA; HOSPITAL DISCHARGE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; SCHOOL CHILD; THROMBOPLASTIN TIME; TIME OF DEATH; TUMOR LOCALIZATION; URETER CARCINOMA; URINARY TRACT CANCER; UROLOGIC EXAMINATION; AGED; CORONARY ARTERY DISEASE; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; UROLOGIC NEOPLASMS;

EID: 0035399851     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01590-9     Document Type: Article

References (17)

1. Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulant, specific antithrombins, thrombolytics IIb-IIIa receptor blockers
2. Heparin after percutaneous intervention (HAPI): A prospective multicenter randomized trial of three heparin regimens after successful coronary intervention
3. Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors
4. Bleeding during anticoagulant therapy
5. Anticoagulant associated hematuria: A prospective study
6. Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment
7. Hematuria inducida por fármacos
8. Bailout coronary stenting with 6F guiding catheters for failed balloon angioplasty
9. Thrombolysis in Myocardial Infarction (TIMI) trial-phase I hemorraghic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
10. Urologic evaluation of hematuria during anticoagulant therapy
11. Bleeding in outpatients treated with warfarin: Relation to the protrombin time and important remediable lesions
12. Anticoagulant-related bleeding: Clinical epidemiology, prediction and prevention
13. Hemorrhagic complications of anticoagulant therapy
14. Unexplained hematuria
15. The evaluation of gross hematuria in anticoagulated patients: Efficacy of i.v. urography and cystoscopy
16. Clinical significance of hematuria in patients on anticoagulant therapy
17. Hamaturie unter anticoagulantientherapie als sympton urologischer erkrankungen